LBA105 Results from SunRISe-1 in patients (Pts) with bacillus Calmette–Guérin (BCG)-unresponsive high-risk non–muscle-invasive bladder cancer (HR NMIBC) receiving TAR-200 monotherapy

Autor: Necchi, A., Jacob, J.M., Daneshmand, S., Simone, G., Xylinas, E., Morris, D., Spiegelhalder, P., Zainfeld, D., Kang, T.W., Matulay, J.T., Belkoff, L., Decaestecker, K., Arentsen, H., Hampras, S., Cutie, C., Sweiti, H., Stromberg, K., Martin, J., Shukla, A., van der Heijden, M.S.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1343-S1344
Databáze: ScienceDirect